Development, validation, and proof-of-concept implementation of a two-year risk prediction model for undiagnosed atrial fibrillation using common electronic health data (UNAFIED).


Journal

BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682

Informations de publication

Date de publication:
03 04 2021
Historique:
received: 09 11 2020
accepted: 26 03 2021
entrez: 4 4 2021
pubmed: 5 4 2021
medline: 24 4 2021
Statut: epublish

Résumé

Many patients with atrial fibrillation (AF) remain undiagnosed despite availability of interventions to reduce stroke risk. Predictive models to date are limited by data requirements and theoretical usage. We aimed to develop a model for predicting the 2-year probability of AF diagnosis and implement it as proof-of-concept (POC) in a production electronic health record (EHR). We used a nested case-control design using data from the Indiana Network for Patient Care. The development cohort came from 2016 to 2017 (outcome period) and 2014 to 2015 (baseline). A separate validation cohort used outcome and baseline periods shifted 2 years before respective development cohort times. Machine learning approaches were used to build predictive model. Patients ≥ 18 years, later restricted to age ≥ 40 years, with at least two encounters and no AF during baseline, were included. In the 6-week EHR prospective pilot, the model was silently implemented in the production system at a large safety-net urban hospital. Three new and two previous logistic regression models were evaluated using receiver-operating characteristics. Number, characteristics, and CHA After restricting age to ≥ 40 years, 31,474 AF cases (mean age, 71.5 years; female 49%) and 22,078 controls (mean age, 59.5 years; female 61%) comprised the development cohort. A 10-variable model using age, acute heart disease, albumin, body mass index, chronic obstructive pulmonary disease, gender, heart failure, insurance, kidney disease, and shock yielded the best performance (C-statistic, 0.80 [95% CI 0.79-0.80]). The model performed well in the validation cohort (C-statistic, 0.81 [95% CI 0.8-0.81]). In the EHR pilot, 7916/22,272 (35.5%; mean age, 66 years; female 50%) were identified as higher risk for AF; 5582 (70%) had CHA Using variables commonly available in the EHR, we created a predictive model to identify 2-year risk of developing AF in those previously without diagnosed AF. Successful POC implementation of the model in an EHR provided a practical strategy to identify patients who may benefit from interventions to reduce their stroke risk.

Sections du résumé

BACKGROUND
Many patients with atrial fibrillation (AF) remain undiagnosed despite availability of interventions to reduce stroke risk. Predictive models to date are limited by data requirements and theoretical usage. We aimed to develop a model for predicting the 2-year probability of AF diagnosis and implement it as proof-of-concept (POC) in a production electronic health record (EHR).
METHODS
We used a nested case-control design using data from the Indiana Network for Patient Care. The development cohort came from 2016 to 2017 (outcome period) and 2014 to 2015 (baseline). A separate validation cohort used outcome and baseline periods shifted 2 years before respective development cohort times. Machine learning approaches were used to build predictive model. Patients ≥ 18 years, later restricted to age ≥ 40 years, with at least two encounters and no AF during baseline, were included. In the 6-week EHR prospective pilot, the model was silently implemented in the production system at a large safety-net urban hospital. Three new and two previous logistic regression models were evaluated using receiver-operating characteristics. Number, characteristics, and CHA
RESULTS
After restricting age to ≥ 40 years, 31,474 AF cases (mean age, 71.5 years; female 49%) and 22,078 controls (mean age, 59.5 years; female 61%) comprised the development cohort. A 10-variable model using age, acute heart disease, albumin, body mass index, chronic obstructive pulmonary disease, gender, heart failure, insurance, kidney disease, and shock yielded the best performance (C-statistic, 0.80 [95% CI 0.79-0.80]). The model performed well in the validation cohort (C-statistic, 0.81 [95% CI 0.8-0.81]). In the EHR pilot, 7916/22,272 (35.5%; mean age, 66 years; female 50%) were identified as higher risk for AF; 5582 (70%) had CHA
CONCLUSIONS
Using variables commonly available in the EHR, we created a predictive model to identify 2-year risk of developing AF in those previously without diagnosed AF. Successful POC implementation of the model in an EHR provided a practical strategy to identify patients who may benefit from interventions to reduce their stroke risk.

Identifiants

pubmed: 33812369
doi: 10.1186/s12911-021-01482-1
pii: 10.1186/s12911-021-01482-1
pmc: PMC8019173
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112

Subventions

Organisme : AHRQ HHS
ID : K12 HS026390
Pays : United States

Références

Health Aff (Millwood). 2014 Jul;33(7):1148-54
pubmed: 25006140
N Engl J Med. 2019 Nov 14;381(20):1909-1917
pubmed: 31722151
Eur Heart J. 2020 Mar 7;41(10):1075-1085
pubmed: 31811716
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Circ Res. 2017 Oct 13;121(9):1092-1101
pubmed: 28794054
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
J Atr Fibrillation. 2019 Jun 30;12(1):2141
pubmed: 31687065
JAMA. 2018 Aug 7;320(5):478-484
pubmed: 30088016
JAMA Netw Open. 2020 Jan 3;3(1):e1919396
pubmed: 31951272
PLoS Med. 2019 Sep 25;16(9):e1002903
pubmed: 31553733
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
J Am Heart Assoc. 2013 Mar 18;2(2):e000102
pubmed: 23537808
Arch Intern Med. 2010 Nov 22;170(21):1909-17
pubmed: 21098350
Am J Cardiol. 2013 Oct 15;112(8):1142-7
pubmed: 23831166
JAMA. 2018 Aug 7;320(5):485-498
pubmed: 30088015
Am J Cardiol. 2011 Jan;107(1):85-91
pubmed: 21146692
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
Thromb Haemost. 2018 Sep;118(9):1556-1563
pubmed: 30103243
JACC Clin Electrophysiol. 2019 Nov;5(11):1331-1341
pubmed: 31753441
Circulation. 2019 Jul 9;140(2):e125-e151
pubmed: 30686041
PLoS One. 2018 Apr 12;13(4):e0195088
pubmed: 29649277

Auteurs

Randall W Grout (RW)

Center for Biomedical Informatics, Regenstrief Institute, 1101 W Tenth St, Indianapolis, IN, 46202, USA. rgrout@iu.edu.
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA. rgrout@iu.edu.

Siu L Hui (SL)

Center for Biomedical Informatics, Regenstrief Institute, 1101 W Tenth St, Indianapolis, IN, 46202, USA.
Research Services, Regenstrief Institute, Indianapolis, IN, USA.
Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA.

Timothy D Imler (TD)

Center for Biomedical Informatics, Regenstrief Institute, 1101 W Tenth St, Indianapolis, IN, 46202, USA.
Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA.

Sarah El-Azab (S)

Research Services, Regenstrief Institute, Indianapolis, IN, USA.

Jarod Baker (J)

Center for Biomedical Informatics, Regenstrief Institute, 1101 W Tenth St, Indianapolis, IN, 46202, USA.

George H Sands (GH)

Pfizer Inc, US Medical Affairs, New York, NY, USA.

Mohammad Ateya (M)

Pfizer Inc, US Medical Affairs, New York, NY, USA.

Francis Pike (F)

Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH